RESEARCH MONOGRAPH · KDC-MN-112

Reishi (Ganoderma lucidum)

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

59/100

Triterpene and beta-glucan chemistry is real, the human cognitive and immune trials are mostly thin

Reishi (Ganoderma lucidum, or the related G. lingzhi in modern Chinese taxonomy) is the medicinal mushroom with the longest documented history of use in East Asian medicine, going back two millennia in the Chinese herbal canon as a longevity and tonification herb. The marketing volume is enormous, the trial base is much smaller than the marketing suggests, and the chemistry is more interesting than the consumer products usually deliver.

Two active compound classes get most of the attention. The triterpenes (ganoderic acids, with dozens of identified species) are unique to Ganoderma and have shown various activities in cell-based assays including hepatoprotection, immune modulation, and some kinase inhibition. The polysaccharides (beta-D-glucans with specific branching patterns) are the more studied immune modulators, hitting dectin-1 and complement-related pathways. The interplay between the triterpene-rich alcohol fractions and the polysaccharide-rich water fractions is why dual-extraction matters for reishi specifically.

The human trial base is thin. There are small trials in cancer adjunct settings showing some quality-of-life and immune marker improvements, a handful in sleep and anxiety where the results are mixed and the trials are mostly small and methodologically uneven. The sleep effect (which the traditional Chinese use emphasized) doesn't have strong modern RCT support, though anecdotal reports are consistent.

What we like: real bioactive chemistry, dual-extraction matters and reputable suppliers do it properly, beta-glucan immune modulation is at least mechanistically grounded. The long history of safe use is documentary evidence for low acute toxicity at usual doses.

What we dont like is the product quality variance and the marketing claim density. Many commercial reishi products are mycelium-on-grain with essentially zero triterpene content and minimal real beta-glucan. The "spore oil" products focus on a different fraction with different chemistry and the claims about it are largely unsupported.

Sourcing: dual-extracted fruiting body material (Real Mushrooms, Nammex, and a few others publish triterpene and beta-glucan content separately). Look for triterpene content documented as ganoderic acids, not just polysaccharide totals. Spore-based products are a separate category with separate questions. Pure ganoderic acid A or related single compounds are available as research-grade material at high HPLC purity for mechanism work.

Old herb, real chemistry, supplement industry mostly fails to deliver the actives. Treat the consumer products with skepticism.

Evidence: 45
Mechanism: 60
Reliability: 50
Safety: 88
Sourcing: 55
Value: 55
Signal: 55
Staying power: 65

Plain-language summary Intrigue 50 / 100

Reishi (Ganoderma lucidum) is a medicinal mushroom traditionally used in East Asia for longevity, immunity, and sleep. Triterpenes and polysaccharides drive the immunomodulatory effects. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Medicinal mushroom

A medicinal mushroom with traditional use in immune support and longevity, characterized by triterpenoids (ganoderic acids) and beta-glucan polysaccharides.

Abstract

Reishi (Ganoderma lucidum, Lingzhi) is a medicinal mushroom with millennia of traditional use in Chinese medicine for immune support, longevity, and cardiovascular function. Active constituents include triterpenoids (ganoderic acids A through Z), beta-glucan polysaccharides, and ergosterols. Mechanism is multimodal including immunomodulation through TLR agonism (beta-glucans), modest anticancer effects (triterpenoids), and modulation of platelet aggregation. The clinical evidence base in randomized trials is modest; the compound is more of a general adaptogen than a targeted therapeutic. Reported research dose ranges in the literature use mushroom extract.

Mechanism of action

Immunomodulation through beta-glucan TLR agonism; triterpenoid anticancer effects; cardiovascular modulation.

Reported research dose ranges

Reported research dose ranges in the literature describe extract quantities.

References

Lin ZB. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 2005.

Read the full monograph

The full reference document covers compound identification, discovery and developmental history, mechanism of action, pharmacokinetics, reported research dose ranges, sourcing and quality verification, reconstitution and handling, stack interaction considerations, and a curated reference list. Available as a research-use-only PDF download.

KDC-MN-112

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Reishi (Ganoderma lucidum)

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs